日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

HJP 272, an endothelin receptor antagonist, and its role in cancer cell migration and invasion

内皮素受体拮抗剂HJP 272及其在癌细胞迁移和侵袭中的作用

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2025.102492
Baig, Nabeela; Chilamakuri, Rameswari; Agarwal, Saurabh; Muth, Aaron; Reznik, Sandra E
信号转导
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Gankyrin-Protein Interactions in GI Cancers: A Novel Target of New Therapeutics

胃肠道癌症中的 Gankyrin-蛋白质相互作用：新型治疗靶点

期刊:
影响因子:
doi:10.1002/cdt3.70025
Li, Shuang; Lam, Yuky; Muth, Aaron; Chen, Zhe-Sheng; Wang, Shanzhi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin binders

2,5-取代嘧啶类化合物的合成与评价及其作为小分子gankyrin结合剂的性能

期刊:Future Medicinal Chemistry
影响因子:3.4
doi:10.4155/fmc-2023-0124
Kanabar, Dipti; Kane, Emma I; Chavan, Tejashri; Laflamme, Taylor M; Suarez, Ethan; Goyal, Mimansa; Gupta, Vivek; Spratt, Donald E; Muth, Aaron
发表日期：2024
文献求助 收藏

Structural modification of the propyl linker of cjoc42 in combination with sulfonate ester and triazole replacements for enhanced gankyrin binding and anti-proliferative activity

通过对cjoc42的丙基连接基进行结构修饰，并结合磺酸酯和三唑取代，可增强其与gankyrin的结合能力和抗增殖活性。

期刊:Bioorganic & Medicinal Chemistry
影响因子:3
doi:10.1016/j.bmc.2024.117836
Chavan, Tejashri; Kanabar, Dipti; Patel, Kinjal; Laflamme, Taylor M; Riyazi, Maryam; Spratt, Donald E; Muth, Aaron
发表日期：2024
文献求助 收藏

Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer

第二代小分子Gankyrin抑制剂用于治疗儿童肝癌

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14133068
D'Souza, Amber M; Gnanamony, Manu; Thomas, Maria; Hanley, Peter; Kanabar, Dipti; de Alarcon, Pedro; Muth, Aaron; Timchenko, Nikolai
肿瘤
肝癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma.

将抗癫痫药物用于治疗胶质母细胞瘤

期刊:Pharmaceutical Research
影响因子:4.3
doi:10.1007/s11095-022-03399-4
Yadav Anjali, Alnakhli Ali, Vemana Hari Priya, Bhutkar Shraddha, Muth Aaron, Dukhande Vikas V
细胞生物学
发表日期：2022
文献求助 收藏

Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs

仿生粒子工程技术用于非侵入性吸入式肺部药物输送

期刊:Materials Science & Engineering C-Materials for Biological Applications
影响因子:8.1
doi:10.1016/j.msec.2021.112324
Shukla, Snehal K; Sarode, Apoorva; Kanabar, Dipti D; Muth, Aaron; Kunda, Nitesh K; Mitragotri, Samir; Gupta, Vivek
发表日期：2021
文献求助 收藏

Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation - Evaluation of intestinal absorption and anti-cancer activity

通过环糊精络合绕过P-糖蛋白介导的阿法替尼外排——肠道吸收及抗癌活性评价

期刊:Journal of Molecular Liquids
影响因子:5.2
doi:10.1016/j.molliq.2020.114866
Parvathaneni, Vineela; Elbatanony, Rasha S; Shukla, Snehal K; Kulkarni, Nishant S; Kanabar, Dipti D; Chauhan, Gautam; Ayehunie, Seyoum; Chen, Zhe-Sheng; Muth, Aaron; Gupta, Vivek
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes

将贝达喹啉重新用于有效的非小细胞肺癌（NSCLC）治疗，开发为可吸入的环糊精基分子包合物

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms22094783
Parvathaneni, Vineela; Elbatanony, Rasha S; Goyal, Mimansa; Chavan, Tejashri; Vega, Nathan; Kolluru, Srikanth; Muth, Aaron; Gupta, Vivek; Kunda, Nitesh K
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
发表日期：2021
文献求助 收藏

Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).

开发可大规模生产的吸入式抗癌纳米疗法——将阿莫地喹用于治疗非小细胞肺癌（NSCLC）

期刊:Materials Science & Engineering C-Materials for Biological Applications
影响因子:8.1
doi:10.1016/j.msec.2020.111139
Parvathaneni Vineela, Kulkarni Nishant S, Chauhan Gautam, Shukla Snehal K, Elbatanony Rasha, Patel BrijeshKumar, Kunda Nitesh K, Muth Aaron, Gupta Vivek
细胞生物学
肿瘤免疫
发表日期：2020
文献求助 收藏